CGON
CG Oncology, Inc.
+0.96 (+1.30%)75.08USD159K成交股數6.7B市值–本益比(近四季)1068.6股價營收比–營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.2M | 1.1M+1983% | 2.3M+5300% | 1.7M+1401% | 0.00-100% | 52K+5100% | 43K+378% | 111K | 529K | 1K | 9K | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 54.7M | 43.7M | 30.0M | 27.9M | 31.3M | 27.5M | 19.6M | 18.5M | 17.2M | 16.3M | 11.7M | 9.8M |
| 銷售管理費用 | 29.0M | 20.8M | 18.0M | 23.3M | 17.4M | 14.8M | 8.7M | 7.5M | 5.8M | 3.0M | 2.3M | 2.5M |
| 營業利益 | −86.4M+77% | −66.4M+57% | −48.7M+72% | −51.1M+98% | −48.7M+117% | −42.2M+118% | −28.3M+101% | −25.9M+110% | −22.5M | −19.4M | −14.0M | −12.3M |
| 營業利益率 | -7,467.7% | -6,130.1% | -2,097.3% | -3,069.0% | – | -81,161.5% | -65,802.3% | -23,291.0% | -4,247.4% | -1,935,900.0% | -156,033.3% | – |
| 稅後淨利 | −79.1M+91% | −60.2M+75% | −41.3M+102% | −43.8M+132% | −41.4M+145% | −34.5M+108% | −20.4M+73% | −18.9M+63% | −16.9M | −16.6M | −11.8M | −11.6M |
| 淨利率 | -6,832.8% | -5,558.8% | -1,779.2% | -2,629.5% | – | -66,253.8% | -47,453.5% | -17,028.8% | -3,201.1% | -1,655,500.0% | -130,755.6% | – |
| 稀釋 EPS | -0.90+67% | -0.71+58% | -0.52+73% | -0.57+104% | -0.54+50% | -0.45-90% | -0.30-93% | -0.28-93% | -0.36 | -4.50 | -4.00 | -3.93 |
| 稀釋股數 | 88.2M | 84.5M | 77.3M | 76.7M | 76.2M | 76.2M | 67.1M | 66.6M | 47.1M | 4.3M | 4.4M | 3.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 19.6M | 33.7M | 32.5M | 45.1M | 14.6M | 41.5M | 43.4M | 25.2M | 77.5M | 8.3M | 10.3M | 78.0M |
| 應收帳款 | 417K | 1.3M | 688K | 515K | – | – | – | – | – | – | – | – |
| 存貨 | 1.0M | 1.5M | 1.6M | 1.5M | – | – | – | – | – | – | – | – |
| 總資產 | 1.1B | 1.1B | 792M | 730M | 701M | 728M | 552M | 564M | 579M | 199M | – | – |
| 有息負債 | 3.0M | 3.0M | 3.0M | 3.0M | – | – | – | – | – | – | – | – |
| 總負債 | 56.5M | 43.5M | 39.0M | 42.3M | 31.1M | 23.4M | 15.7M | 12.0M | 10.2M | 14.5M | – | – |
| 股東權益 | 1.0B | 1.1B | 753M | 688M | 670M | 705M | 537M | 552M | 569M | −123M | −108M | −97.4M |
| 負債比 | 5.2% | 3.8% | 4.9% | 5.8% | 4.4% | 3.2% | 2.8% | 2.1% | 1.8% | 7.3% | – | – |
| 淨現金(現金 − 有息負債) | 16.6M | 30.7M | 29.5M | 42.1M | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −56.9M+94% | – | – | – | −29.3M | – | – | −26.0M | – | – | – |
| 資本支出 | – | 304K | – | – | – | 16K | – | – | 12K | – | – | – |
| 自由現金流 | – | −57.2M+95% | – | – | – | −29.3M | – | – | −26.0M | – | – | – |
| 折舊攤銷 | – | 841K | – | – | – | 24K | – | – | 4K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -5,286.0% | – | – | – | -56,332.7% | – | – | -4,919.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 4.0M
| Commercial And Development Revenue | 3.2M | 80.0% | – |
|---|---|---|---|
| License And Collaboration Revenue | 806K | 20.0% | -29.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.0M | +254.7% | −161M | -3,985.1% | -2.08 | −132M |
| FY2024 | 1.1M | +458.3% | −88.0M | -7,729.6% | -1.41 | −78.9M |
| FY2023 | 204K | – | −48.6M | -23,827.0% | -15.65 | – |